Clinical trial Recruiting at 1 site Observational Ages 18 and up

Exploring coronary artery disease progression using radial wall strain

Official title: Natural History of Coronary Atherosclerosis Based on Multimodal Imaging and Physiological Fusion Techniques (NASCENT)

Run by China National Center for Cardiovascular Diseases · NCT06040073 · Data updated 2026-11-12

This study is testing if a new way to measure heart artery strain can help predict how quickly heart disease gets worse in people who recently had a heart attack.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment125 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 7, 2024
Main results expectedJune 30, 2025
Study endsDecember 31, 2026
Registry record updatedNovember 6, 2024
Trial IDNCT06040073 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have had an acute myocardial infarction within the last 45 days and are scheduled for coronary angiography.

Probably not a fit

Patients with cardiogenic shock, those who are pregnant, or individuals with a life expectancy of less than one year for non-cardiac causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the predictive value of radial wall strain (RWS) derived from angiograms for the progression of coronary artery lesions compared to lesion vulnerability assessed by optical coherence tomography (OCT). It involves a multicenter, prospective cohort of individuals who have experienced an acute myocardial infarction within the last 45 days. The study aims to determine if RWS can effectively predict disease progression at one year, using a specific threshold for identifying vulnerable lesions. The findings may help optimize strategies for identifying high-risk plaques in patients.

Why it matters

Potential benefit: If successful, this study could enhance the ability to predict coronary artery disease progression, leading to better patient management and outcomes.

How similar studies have gone: While the approach of using radial wall strain is relatively novel, similar studies utilizing optical coherence tomography have shown promise in assessing lesion vulnerability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* General Inclusion Criteria:

  1. Age ≥18 years
  2. Acute myocardial infarction ≤ 45 days
  3. Planned coronary angiography examination or potential interventional treatment
* Angiographic Inclusion Criteria:

  1. The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment

Exclusion Criteria:

* General exclusion Criteria:

  1. Cardiogenic shock
  2. Pregnant or woman of child-bearing potential
  3. Life expectancy less than 1 year for non-cardiac causes
  4. Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy
  5. Prior CABG or planned CABG
* Angiographic exclusion Criteria:

  1. Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement
  2. An interrogated lesion require surgical bypass grafting
  3. Unable to judge culprit lesion or infarct-related artery according to current evidence

Where it's running

  • Lei Song
    Beijing, China
    Recruiting

Study contacts

  • Principal investigator: Lei Song, MD — Chinese Academy of Medical Sciences, Fuwai Hospital
  • Study coordinator: Lei Song, MD
  • Email: drsong@vip.163.com
  • Phone: 01088322564

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.